| Filed On | Filing |
|---|---|
| 16 Sep 2026 |
Form 4: Greenwell Scott A., President, PharMerica
Received 11,973 shares by exercise or conversion ($267K) · Sold 15,099 shares ($874K) |
| 14 Sep 2026 | 144 |
| 06 Aug 2026 | SCHEDULE 13G/A |
| 31 Jul 2026 | SCHEDULE 13G |
| 31 Jul 2026 | 10-Q |
| 31 Jul 2026 | 8-K: Results of Operations and Financial Condition |
| 28 Jul 2026 |
Form 4: Rousseau Jon B, Director
Gave up 56,319 shares to cover exercise price or tax ($4.11M) |
| 27 Jul 2026 | SCHEDULE 13G/A |
| 22 Jun 2026 |
Form 4: Greenwell Scott A., President, PharMerica
Gave up 2,487 shares to cover exercise price or tax ($165K) |
| 12 Jun 2026 |
Form 4: Shah Nigam H., Director
Received 4,013 shares as a grant or award |
| 12 Jun 2026 |
Form 3: Shah Nigam H., Director
No securities owned |
| 12 Jun 2026 | 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure |
| 05 Jun 2026 | SCHEDULE 13D/A |
| 05 Jun 2026 |
Form 4: Kkr Group Partnership L.p., 10% owner and 6 others
Sold 14,669,771 shares ($857M) · Disposed of 324,608 shares (Other Transaction) · Gave 60,190 shares as a gift |
| 05 Jun 2026 |
Form 4: Kkr Phoenix Aggregator L.p., 10% owner and 4 others
Sold 14,669,771 shares ($857M) · Disposed of 324,608 shares (Other Transaction) · Gave 60,190 shares as a gift |
| 05 Jun 2026 |
Form 4: Rousseau Jon B, Director
Received 260,000 shares by exercise or conversion ($1.66M) · Sold 260,000 shares ($15.3M) |
| 05 Jun 2026 |
Form 4: Nalley Lisa A, See Remarks
Received 35,000 shares by exercise or conversion ($223K) · Sold 35,000 shares ($2.06M) |
| 05 Jun 2026 |
Form 4: Phipps Jennifer A, Chief Financial Officer
Received 35,000 shares by exercise or conversion ($223K) · Sold 35,000 shares ($2.06M) |
| 05 Jun 2026 | 8-K: Entry into a Material Definitive Agreement |
| 05 Jun 2026 | 424B7 |
Loading...